Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tami L Mark

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Clinical Therapeutics|December 13, 2006
Drug administration frequency and provider office visit patterns for oncology patients during treatment with erythropoietic agents: an analysis of four observational studiesAntoine Gosselin, Chris L Pashos, Carolyn Harley, et al.
Psychiatric Services (Washington, D.C.)|October 13, 2021
Addiction Treatment and Telehealth: Review of Efficacy and Provider Insights During the COVID-19 PandemicTami L Mark, Katherine Treiman, Howard Padwa, et al.
Journal of Substance Abuse Treatment|April 30, 2015
Medicaid coverage of medications to treat alcohol and opioid dependenceTami L Mark, Robert Lubran, Elinore F McCance-Katz, et al.
Health Affairs (Project Hope)|September 2, 2025
The Quality Of Opioid Use Disorder Treatment In Medicare Is Low And Lags Behind MedicaidTami L Mark, William J Parish, Deborah Steinberg, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 23, 2003
Risk adjustment for people with chronic conditions in private sector health plansTami L Mark, Ronald J Ozminkowski, Adele Kirk, et al.
Journal of Substance Abuse Treatment|August 4, 2020
Adherence to buprenorphine treatment guidelines among individuals with an opioid use disorder who have private insuranceTami L Mark, Jesse M Hinde, Gary A Zarkin, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2015
National estimates of behavioral health conditions and their treatment among adults newly insured under the ACATami L Mark, Lauren M Wier, Kevin Malone, et al.
Drug and Alcohol Dependence|July 8, 2021
Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use?Tami L Mark, Jesse M Hinde, Alan Barnosky, et al.
Journal of Managed Care Pharmacy : JMCP|July 4, 2008
Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's diseaseLisa Mucha, Sara Shaohung, Brian Cuffel, et al.
Journal of Addiction Medicine|June 2, 2023
Improving Research on Racial Disparities in Access to Medications to Treat Opioid Use DisordersTami L Mark, La Sonya A Goode, Gary McMurtrie, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Clinical Therapeutics|December 13, 2006
Drug administration frequency and provider office visit patterns for oncology patients during treatment with erythropoietic agents: an analysis of four observational studiesAntoine Gosselin, Chris L Pashos, Carolyn Harley, et al.
Psychiatric Services (Washington, D.C.)|October 13, 2021
Addiction Treatment and Telehealth: Review of Efficacy and Provider Insights During the COVID-19 PandemicTami L Mark, Katherine Treiman, Howard Padwa, et al.
Journal of Substance Abuse Treatment|April 30, 2015
Medicaid coverage of medications to treat alcohol and opioid dependenceTami L Mark, Robert Lubran, Elinore F McCance-Katz, et al.
Health Affairs (Project Hope)|September 2, 2025
The Quality Of Opioid Use Disorder Treatment In Medicare Is Low And Lags Behind MedicaidTami L Mark, William J Parish, Deborah Steinberg, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 23, 2003
Risk adjustment for people with chronic conditions in private sector health plansTami L Mark, Ronald J Ozminkowski, Adele Kirk, et al.
Journal of Substance Abuse Treatment|August 4, 2020
Adherence to buprenorphine treatment guidelines among individuals with an opioid use disorder who have private insuranceTami L Mark, Jesse M Hinde, Gary A Zarkin, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2015
National estimates of behavioral health conditions and their treatment among adults newly insured under the ACATami L Mark, Lauren M Wier, Kevin Malone, et al.
Drug and Alcohol Dependence|July 8, 2021
Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use?Tami L Mark, Jesse M Hinde, Alan Barnosky, et al.
Journal of Managed Care Pharmacy : JMCP|July 4, 2008
Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's diseaseLisa Mucha, Sara Shaohung, Brian Cuffel, et al.
Journal of Addiction Medicine|June 2, 2023
Improving Research on Racial Disparities in Access to Medications to Treat Opioid Use DisordersTami L Mark, La Sonya A Goode, Gary McMurtrie, et al.
Pageof 13